354 related articles for article (PubMed ID: 19479807)
1. Graft rejection occurring in post-liver transplant patients receiving cytotoxic chemotherapy: a case series.
Tan HH; Fiel MI; del Rio Martin J; Schiano TD
Liver Transpl; 2009 Jun; 15(6):634-9. PubMed ID: 19479807
[TBL] [Abstract][Full Text] [Related]
2. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
[TBL] [Abstract][Full Text] [Related]
3. Late acute rejection after liver transplantation impacts patient survival.
Uemura T; Ikegami T; Sanchez EQ; Jennings LW; Narasimhan G; McKenna GJ; Randall HB; Chinnakotla S; Levy MF; Goldstein RM; Klintmalm GB
Clin Transplant; 2008; 22(3):316-23. PubMed ID: 18190550
[TBL] [Abstract][Full Text] [Related]
4. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
Pedrosa MC; Rohrer RM; Kaplan MM
Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
[TBL] [Abstract][Full Text] [Related]
5. Significance of central perivenulitis in pediatric liver transplantation.
Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
[TBL] [Abstract][Full Text] [Related]
6. Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus.
Fiel MI; Agarwal K; Stanca C; Elhajj N; Kontorinis N; Thung SN; Schiano TD
Liver Transpl; 2008 Jun; 14(6):861-71. PubMed ID: 18508382
[TBL] [Abstract][Full Text] [Related]
7. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence.
Venkat VL; Nick TG; Wang Y; Bucuvalas JC
Pediatr Transplant; 2008 Feb; 12(1):67-72. PubMed ID: 18186891
[TBL] [Abstract][Full Text] [Related]
8. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN
Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339
[TBL] [Abstract][Full Text] [Related]
10. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
[TBL] [Abstract][Full Text] [Related]
11. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
[TBL] [Abstract][Full Text] [Related]
12. The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients.
Urbani L; Mazzoni A; Catalano G; De Simone P; Vanacore R; Pardi C; Bortoli M; Biancofiore G; Campani D; Perrone V; Mosca F; Scatena F; Filipponi F
Transplant Proc; 2004 Dec; 36(10):3068-70. PubMed ID: 15686696
[TBL] [Abstract][Full Text] [Related]
13. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults.
Heneghan MA; Portmann BC; Norris SM; Williams R; Muiesan P; Rela M; Heaton ND; O'Grady JG
Hepatology; 2001 Sep; 34(3):464-70. PubMed ID: 11526530
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation.
Gibelli NE; Tannuri U; Mello ES; Cançado ER; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Pinho-Apezzato ML; Maksoud JG
Pediatr Transplant; 2006 May; 10(3):371-6. PubMed ID: 16677364
[TBL] [Abstract][Full Text] [Related]
15. Late acute liver allograft rejection; a study of its natural history and graft survival in the current era.
Thurairajah PH; Carbone M; Bridgestock H; Thomas P; Hebbar S; Gunson BK; Shah T; Neuberger J
Transplantation; 2013 Apr; 95(7):955-9. PubMed ID: 23442806
[TBL] [Abstract][Full Text] [Related]
16. [Liver disease recurrence after liver transplantation].
Rakela B J
Rev Med Chil; 2010 Apr; 138(4):504-10. PubMed ID: 20668801
[TBL] [Abstract][Full Text] [Related]
17. Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence.
Nakhleh RE; Krishna M; Keaveny AP; Dickson RC; Rosser B; Nguyen JH; Steers JL
Transplant Proc; 2005 Mar; 37(2):1240-2. PubMed ID: 15848682
[TBL] [Abstract][Full Text] [Related]
18. Smoking behavior in liver transplant recipients.
van der Heide F; Dijkstra G; Porte RJ; Kleibeuker JH; Haagsma EB
Liver Transpl; 2009 Jun; 15(6):648-55. PubMed ID: 19479809
[TBL] [Abstract][Full Text] [Related]
19. Bone disease in liver transplant recipients: incidence, timing, and risk factors.
Porayko MK; Wiesner RH; Hay JE; Krom RA; Dickson ER; Beaver S; Schwerman L
Transplant Proc; 1991 Feb; 23(1 Pt 2):1462-5. PubMed ID: 1989266
[No Abstract] [Full Text] [Related]
20. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.
Alabraba E; Nightingale P; Gunson B; Hubscher S; Olliff S; Mirza D; Neuberger J
Liver Transpl; 2009 Mar; 15(3):330-40. PubMed ID: 19243003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
